James Kuo

James Kuo

Founder presso TRYP THERAPEUTICS INC.

Patrimonio netto: 146 760 $ in data 31/03/2024

58 anni
Health Technology
Finance
Consumer Services

Profilo

James S.
Kuo
was the founder of Windtree Therapeutics, Inc. (founded in 1992) and BioMicro Systems, Inc. (founded in 2003), where he held the titles of President & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He is also the founder of Tryp Therapeutics, Inc. (founded in 2019) and currently serves as a Director.
Dr. Kuo is also the founder of Monarch Labs, Inc. Dr. Kuo's current jobs include Chairman & Chief Executive Officer at ApoLife, Inc. (since 2012), Chief Executive Officer at Return Health, Inc., Non-Executive Chairman at MSK Pharma LLC, Independent Director at Pharnext SA (starting in 2022), Managing Director at Athena Bioventures, Inc. (since 2007), and Vice President-Research & Development at Silo Pharma, Inc. (starting in 2022).
His former jobs include Chief Executive Officer & IR Contact at FIT Biotech Oy (2016-2018), Chairman & Chief Executive Officer at Cysteine Pharma, Inc. (2006-2007), Chief Executive Officer at OncoTracker, Inc. (2018-2019), Chairman & Chief Executive Officer at KMRB Acquisition Corp.
II, Non-Executive Chairman at Soligenix, Inc. (2004-2009), Chairman at ImmunoPrecise Antibodies Ltd.
(2016-2023), Associate Director-Corporate Licensing at Pfizer Inc. (1995-1997), Managing Director-Venture Analysis at HealthCare Ventures LLC, Director at Cordex Pharma, Inc. (2007-2010), Director at Theriva Biologics, Inc. (2007-2012), and Vice President-Business Development at Myriad Genetics, Inc. (1998-2000).
Dr. Kuo's education includes an undergraduate degree from Haverford College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.
Dr. Kuo is also the founder of Monarch Labs, Inc...

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
09/01/2024 6 000 000 ( 6.22% ) 108 000 $ 31/03/2024
17/03/2023 25 500 ( 0.10% ) 38 760 $ 31/03/2024

Posizioni attive di James Kuo

SocietàPosizioneInizio
TRYP THERAPEUTICS INC. Founder -
PHARNEXT SCA Director/Board Member 16/06/2022
SILO PHARMA, INC. Chief Tech/Sci/R&D Officer 01/09/2022
Chief Executive Officer -
Corporate Officer/Principal 01/01/2007
Chief Executive Officer 27/09/2012
MSK Pharma LLC Chairman 11/04/2011
Founder -
Tutte le posizioni attive di James Kuo

Precedenti posizioni note di James Kuo

SocietàPosizioneFine
IMMUNOPRECISE ANTIBODIES LTD. Chairman 09/11/2023
░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di James Kuo

Formazione di James Kuo

Haverford College Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
University of Pennsylvania Medical Center Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James Kuo

Relazioni

100 +

Relazioni di 1° grado

24

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa9
SOLIGENIX, INC.

Health Technology

PFIZER, INC.

Health Technology

WINDTREE THERAPEUTICS, INC.

Health Technology

MYRIAD GENETICS, INC.

Health Technology

SILO PHARMA, INC.

Health Technology

THERIVA BIOLOGICS, INC.

Health Technology

PHARNEXT SCA

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

TRYP THERAPEUTICS INC.

Health Technology

Aziende private12

Health Technology

Finance

Health Technology

Process Industries

Health Technology

Commercial Services

Cysteine Pharma, Inc.

MSK Pharma LLC

Finance

Finance

Health Technology

Health Technology

Vedi le connessioni aziendali